Hinge Health Triumphs in IPO at Top End Price
Deal News | May 22, 2025 | Top Technology Ventures Ltd
Hinge Health, a portfolio company of IP Group, recently priced its initial public offering (IPO) at $32 per share, the top end of its projected range. The company is set to trade on the New York Stock Exchange under the ticker symbol HNGE and the offering concludes on May 23, 2025. IP Group, one of Hinge Health's founding investors, has initially realized a return of 1.0m GBP from a partial sale and plans to allocate 50% to a share buyback program. Their remaining stake is valued at 25.6m GBP based on the IPO price. Given their original investment of under 1.0m and a previous return of $15.0m, this IPO signifies a return over 40 times their original investment, showcasing IP Group's success in backing promising startups like Hinge Health. This IPO marks a significant financial and strategic milestone for Hinge Health, which employs advanced software solutions for musculoskeletal care, streamlining various aspects from injury prevention to rehabilitation. Headquartered in San Francisco, the company remains dedicated to improving health outcomes through technology.
Sectors
- Healthcare Technology
- Investment and Financial Services
Geography
- United States – Hinge Health is headquartered in San Francisco, California, and the IPO is listed on the New York Stock Exchange.
- United Kingdom – IP Group is a UK-based early-stage science investor, operating from the UK and supporting companies like Hinge Health.
Industry
- Healthcare Technology – Hinge Health operates within the Healthcare Technology sector by providing AI-driven solutions for musculoskeletal care, offering innovative platforms for pain management and post-surgical rehabilitation.
- Investment and Financial Services – IP Group operates within the Investment and Financial Services industry, providing funding and support to innovative science and technology companies, evidenced by their investment in Hinge Health.
Financials
- $32 – IPO price per share for Hinge Health.
- 40x – Return multiple on IP Group's investment in Hinge Health.
- 1.0m GBP – Initial proceeds realized by IP Group from partial sale following Hinge Health's IPO.
- 25.6m GBP – Current value of IP Group's remaining stake in Hinge Health calculated at the IPO price.
- $15.0m – Amount realized by IP Group in a previous funding round for Hinge Health in 2021.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Hinge Health Inc. | Target Company | Companies | A healthcare technology company focused on musculoskeletal care, using innovative AI solutions. |
| IP Group plc | Bidding Company | Companies | An investment company providing early-stage funding to science and technology firms, notable for its backing of Hinge Health. |
| New York Stock Exchange | Other | Companies | The stock exchange where Hinge Health's IPO is listed. |
| Dan Perez | CEO | People | CEO of Hinge Health, recognized for his entrepreneurial spirit in guiding the company to a successful IPO. |
| Greg Smith | Chief Executive | People | Chief Executive of IP Group, overseeing their successful investment strategies. |